1	NF-AT	NF-AT	_	_	_	_	_	_	_
2	activation	activation	_	_	_	_	_	_	_
3	induced	induce	_	_	_	_	_	_	_
4	by	by	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	CAML-interacting	caml-interacting	_	_	_	_	_	_	_
7	member	member	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	tumor	tumor	_	_	_	_	_	_	_
11	necrosis	necrosis	_	_	_	_	_	_	_
12	factor	factor	_	_	_	_	_	_	_
13	receptor	receptor	_	_	_	_	_	_	_
14	superfamily	superfamily	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Activation	Activation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	nuclear	nuclear	_	_	_	_	_	_	_
5	factor	factor	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	activated	activate	_	_	_	_	_	_	_
8	T	t	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	transcription	transcription	_	_	_	_	_	_	_
11	factor	factor	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	NF-AT	NF-AT	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	is	be	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	key	key	_	_	_	_	_	_	_
18	event	event	_	_	_	_	_	_	_
19	underlying	underlie	_	_	_	_	_	_	_
20	lymphocyte	lymphocyte	_	_	_	_	_	_	_
21	action	action	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	CAML	CAML	_	_	_	_	_	_	_
3	(	(	_	_	_	_	_	_	_
4	calcium-modulator	calcium-modulator	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	cyclophilin	cyclophilin	_	_	_	_	_	_	_
7	ligand	ligand	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	protein	protein	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	coinducer	coinducer	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	NF-AT	NF-AT	_	_	_	_	_	_	_
15	activation	activation	_	_	_	_	_	_	_
16	when	when	_	_	_	_	_	_	_
17	overexpressed	overexpresse	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	Jurkat	Jurkat	_	_	_	_	_	_	_
20	T	t	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	member	member	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	tumor	tumor	_	_	_	_	_	_	_
6	necrosis	necrosis	_	_	_	_	_	_	_
7	factor	factor	_	_	_	_	_	_	_
8	receptor	receptor	_	_	_	_	_	_	_
9	superfamily	superfamily	_	_	_	_	_	_	_
10	was	be	_	_	_	_	_	_	_
11	isolated	isolate	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	virtue	virtue	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	its	its	_	_	_	_	_	_	_
16	affinity	affinity	_	_	_	_	_	_	_
17	for	for	_	_	_	_	_	_	_
18	CAML	CAML	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Cross-linking	cross-linking	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	this	this	_	_	_	_	_	_	_
4	lymphocyte-specific	lymphocyte-specific	_	_	_	_	_	_	_
5	protein	protein	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	designated	designate	_	_	_	_	_	_	_
8	TACI	TACI	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	transmembrane	transmembrane	_	_	_	_	_	_	_
11	activator	activator	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	CAML-interactor	CAML-interactor	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	on	on	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	surface	surface	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	transfected	transfecte	_	_	_	_	_	_	_
21	Jurkat	Jurkat	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	with	with	_	_	_	_	_	_	_
24	TACI-specific	taci-specific	_	_	_	_	_	_	_
25	antibodies	antibody	_	_	_	_	_	_	_
26	led	lead	_	_	_	_	_	_	_
27	to	to	_	_	_	_	_	_	_
28	activation	activation	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	transcription	transcription	_	_	_	_	_	_	_
32	factors	factor	_	_	_	_	_	_	_
33	NF-AT	NF-AT	_	_	_	_	_	_	_
34	,	,	_	_	_	_	_	_	_
35	AP-1	ap-1	_	_	_	_	_	_	_
36	,	,	_	_	_	_	_	_	_
37	and	and	_	_	_	_	_	_	_
38	NFkappaB	NFkappaB	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	TACI-induced	taci-induced	_	_	_	_	_	_	_
2	activation	activation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	NF-AT	NF-AT	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	specifically	specifically	_	_	_	_	_	_	_
7	blocked	block	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	dominant-negative	dominant-negative	_	_	_	_	_	_	_
11	CAML	caml	_	_	_	_	_	_	_
12	mutant	mutant	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	thus	thus	_	_	_	_	_	_	_
15	implicating	implicate	_	_	_	_	_	_	_
16	CAML	CAML	_	_	_	_	_	_	_
17	as	as	_	_	_	_	_	_	_
18	a	a	_	_	_	_	_	_	_
19	signaling	signaling	_	_	_	_	_	_	_
20	intermediate	intermediate	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

